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Abstract
Background: While low socioeconomic status (SES) has been associated with inferior cancer outcome among adults, its
impact in pediatric oncology is unclear. Our objective was therefore to conduct a systematic review to determine the impact
of SES upon outcome in children with cancer.
Methods: We searched Ovid Medline, EMBASE and CINAHL from inception to December 2012. Studies for which survivalrelated outcomes were reported by socioeconomic subgroups were eligible for inclusion. Two reviewers independently
assessed articles and extracted data. Given anticipated heterogeneity, no quantitative meta-analyses were planned a priori.
Results: Of 7,737 publications, 527 in ten languages met criteria for full review; 36 studies met final inclusion criteria. In lowand middle-income countries (LMIC), lower SES was uniformly associated with inferior survival, regardless of the measure
chosen. The majority of associations were statistically significant. Of 52 associations between socioeconomic variables and
outcome among high-income country (HIC) children, 38 (73.1%) found low SES to be associated with worse survival, 15 of
which were statistically significant. Of the remaining 14 (no association or high SES associated with worse survival), only one
was statistically significant. Both HIC studies examining the effect of insurance found uninsured status to be statistically
associated with inferior survival.
Conclusions: Socioeconomic gradients in which low SES is associated with inferior childhood cancer survival are ubiquitous
in LMIC and common in HIC. Future studies should elucidate mechanisms underlying these gradients, allowing the design
of interventions mediating socioeconomic effects. Targeting the effect of low SES will allow for further improvements in
childhood cancer survival.
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survival (EFS), overall survival (OS) and disease-free survival (DFS)
among children with cancer. Secondary objectives included
determining the effect of other SES measures, as well as the effect
of SES on treatment-related mortality (TRM), relapse and
abandonment of therapy.

Introduction
Socioeconomic status (SES), a multi-dimensional construct
encompassing economic resources, power and social standing,
has been associated with a number of health outcomes.[1–4]
Understanding the mechanisms behind such associations is
necessary in order to reduce health disparities. Among adult
patients, strong evidence exists supporting socioeconomic gradients in cancer mortality. [5].
By contrast, the equivalent pediatric literature is sparse and
predominantly restricted to low- and middle-income countries
(LMIC). [6,7] High-income country (HIC) studies have yielded
seemingly contradictory results.[8–10] Given differences in cure
rates and developmental position, adult socioeconomic gradients
cannot be extrapolated to children with cancer.
We therefore undertook the first systematic review of the
literature examining the impact of SES upon pediatric oncology
outcomes. Our primary objective was to determine the impact of
income- and education-based measures of SES on event-free
PLOS ONE | www.plosone.org

Methods
The conduct of the review followed the PRISMA framework.
[11] Both the PRISMA Checklist and the initial protocol can be
found in Checklist S1 and Text S1.

Data Sources
We performed electronic searches of Ovid Medline, EMBASE
and CINAHL from inception to December 10th, 2012 with the
assistance of a library scientist. The Medline search strategy is
illustrated in Table 1, with complete strategies illustrated in Text
S2.
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Table 1. Medline Search Strategy.

Set

History

Results

Comments

1

‘‘emigration and immigration’’/or residence characteristics/or ‘‘catchment area (health)
’’/or housing/or public housing/or health status disparities/or Healthcare Disparities/or rural
health services/or suburban health services/or urban health services/or exp Insurance/or
exp Health Services Accessibility/or exp Socioeconomic Factors/

54,3627

SES Terms

2

Exp Neoplasms/

2,416,057

Neoplasm terms

3

1 and 2

3,227,924

Base clinical set

4

limit 3 to ‘‘all child (0 to 18 years)’’

4,042

Age group limit

5

(infan* or child* or adolescen* or youth* or
teen* or pediatric* or paediatric*).mp.

2,961,284

Age group textword terms

6

4 or (3 and 5)

4,533

FINAL Results

doi:10.1371/journal.pone.0089482.t001

(TRM, relapse, abandonment). Relative survival was assumed to
be comparable to OS. Multiple measures of SES exist in the
literature, reflecting three main domains: material resources,
knowledge related assets and social standing. [14] Though income
and education (including measures of occupation) were the key
variables of interest in this study, we included a broad range of
SES measures reflecting these domains: material possession (e.g.
car ownership), family composition (e.g. marital status), health
insurance status, health care accessibility and immigrant status.
Both ecologic and individual-level variables were included. When
measures over multiple time periods were available, only the most
contemporaneous time period was recorded. Study authors were
contacted to solicit missing data.
Study quality was assessed using a framework of potential biases
developed by Hayden et?al to evaluate prognosis studies. [15]
Four key indicators of study quality relevant for studies examining
the impact of SES were identified a priori: (1) the degree to which
study samples reflected underlying populations, (2) whether loss to
follow-up was associated with socioeconomic characteristics, (3)
whether potential confounders were accounted for and (4) the
appropriateness of the analysis. Further details are provided in the
online supplemental data. When assessing the degree to which
study samples represented the general population, samples derived
from clinical trials were judged to be only partly representative of

Study Selection
Inclusion and exclusion criteria were defined a priori. Inclusion
criteria were: (1) ecologic, cross-sectional, cohort, case-control or
randomized control trial designs; (2) pediatric data available, with
pediatric ages defined by authors, and (3) at least one pre-specified
survival-related outcome reported by subgroups defined by a prespecified socioeconomic variable (see below). Biologic factors may
account for a portion of the disparities in outcome seen between
different ethnic groups. [12] Since the independent effects of
biology and SES cannot be disentangled when ethnicity is the sole
proxy of SES, such studies were excluded. There was no restriction
by language. Two reviewers (SG, MW) independently evaluated
identified titles and abstracts, retrieved any potentially relevant
manuscript and determined eligibility; discrepancies were resolved
through consensus. Agreement between reviewers was assessed
using the kappa statistic. [13] Non-English articles were assessed
with the assistance of pediatric oncologists whom were native
speakers of the relevant language.

Data Abstraction
Two reviewers (SG, MW) independently abstracted data using
standardized forms. The primary outcomes were EFS, OS and
DFS; secondary outcomes were specific causes of treatment failure

Figure 1. PRISMA flow diagram.
doi:10.1371/journal.pone.0089482.g001

PLOS ONE | www.plosone.org

2

February 2014 | Volume 9 | Issue 2 | e89482

Socioeconomic Status and Childhood Cancer

Table 2. Characteristics of included studies.

Studies, N (%)

Characteristic

LMIC (N = 10)

HIC (N = 26)

All cancers

0 (0.0)

8 (30.8)

Leukemia or lymphoma

9 (90.0)

15 (57.7)

Solid tumor

1 (10.0)

1 (3.8)

Central nervous system tumor

0 (0.0)

2 (7.7)

13 (50.0)

Malignancy

Type of socioeconomic variable examined
Ecologic

1 (10.0)

Income-based

7 (70.0)

2 (7.7)

Education-baseda

6 (60.0)

10 (38.5)

Otherb

5 (50.0)

10 (38.5)

Sample Size
,100

1 (10.0)

4 (15.4)

100–999

9 (90.0)

9 (34.6)

1,000–9,999

0 (0.0)

12 (46.2)

$10,000

0 (0.0)

1 (3.8)

Restricted to adolescents/young adultsc
Yes

0 (0.0)

2 (7.7)

No

10 (100.0)

24 (92.3)

Yes

8 (80.0)

21 (80.7)

No/Partial/Unsure

2 (20.0)

5 (19.2)

Yes

3 (30.0)

21 (80.7)

No/Partial/Unsure

1 (10.0)

5 (19.2)

Not applicable

6 (60.0)

0 (0.0)

Yes

6 (60.0)

12 (46.2)

No/Partial/Unsure

4 (40.0)

14 (53.8)

Yes

8 (80.0)

18 (69.2)

No/Partial/Unsure

2 (20.0)

8 (30.8)

Study sample adequately reflective of general populationd

Loss to follow-up unrelated to socioeconomic statusd

Potential confounders accounted ford

Analysis appropriate

d

HIC – high-income countries; LMIC – low- and middle-income countries.
Also included occupation-based measures of socioeconomic status.
b
Included measures of material possession, family composition, insurance status, immigrant status, and health care accessibility.
c
As defined by study authors.
d
See supplemental data for definitions of study quality variables.
doi:10.1371/journal.pone.0089482.t002
a

the overall population, as patients of low SES who consent to trials
may be systematically different than those who do not. [16,17]
Single institution studies were also assessed as only partly representative. The loss to follow-up quality indicator was judged not
applicable for settings in which abandonment of therapy
constituted a significant cause of treatment failure. [18] As various
indicators measure different domains of socioeconomic position,
accounting for confounding was assessed as adequate if both a
measure of disease risk and a second SES indicator were included.
Analyses that were not based on time-to-event data were assessed
as partially adequate.

PLOS ONE | www.plosone.org

Analysis
Given the anticipated heterogeneity in settings, SES measures
and malignancies, no quantitative meta-analyses were planned.
The magnitude and underlying mechanisms of any association
between SES and outcome are likely to differ between developing
and developed countries. The results were therefore summarized
separately for LMIC and for HIC, as defined by the World Bank
using Gross National Income per capita (LMIC ,$12,616 vs. HIC
$$12,616). [19].
As the unit of analysis varied markedly even among studies
investigating a common SES variable (e.g. per unit of monthly
income vs. per income quintile), we could not compare
magnitudes of association across studies. Consequently, measures
of association between SES and outcome were plotted on a single

3
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–

–

ALL

Tang 2008

4

–

–
532

–

ALL

–
Abandonment

–

Abandonment

–

–

TRM

–

DFS

OS

OS

EFS

EFS

EFS

–

EFS

–

EFS

Outcome
Measure

.
HR 5.4; Low vs.
high Kuppuswami scoreb
Family income NS
–

–
–
–
HR 2.38; Most
marginalized vs. least

Maternal education NS
–

–
Kuppuswami score NSb

Paternal education NS

–

–

–

–

–

Parental education NS

–

–

–

Maternal education NS

–

.

–

Parental
education NS

–

–

–

–

–

Monthly income NS

–
–

–

–

5-year DFS 58% for those
.0.4 6
minimum wage vs. 8%
for those ,0.4 6
minimum wage; p,0.0001

HR 2.6; 2nd/3rd class ward vs.
VIP/1st class ward, based on
income

–

–

–

Monthly
income NS

–

–

–

HR 0.49; $Secondary
vs.
#primary

HR 0.84; Per $100
increase

–

–

Education Measuresa

Income Measures

Ecologic Measures

–

–

32.5% abandonment good
housing conditions
vs. 83.3% poor; p,0.001

Cost to travel to clinic NS

Number of family members NS

Telephone ownership NS

Very poor vs. fair-good housing
conditions; p = 0.006

.4 kw hours daily electric
consumption vs.
,4 kw hours; p = 0.0003

–

–

–

5-year EFS 61.2% urban vs. 30.3%
rural; p,0.0001c

.

Mode of transport NS

Telephone ownership NS

Mode of transport NS

Telephone ownership NS

Other SES Measures

ALL – acute lymphoblastic leukemia; AML – acute myeloid leukemia; DFS – disease free survival; EFS – event free survival; HR – hazard ratio; N – number; NS – non-significant; OS – overall survival; SES – socioeconomic status; TRM –
treatment related mortality.
Bolded variables indicate statistically significant associations. Magnitudes of non-significant associations and confidence intervals of significant associations can be found in Table S1, along with definitions of each variable.
a
Education measures also include occupation-based measures.
b
Aggregate score based on income, education and occupation.
c
Urban residents also had medical insurance while rural residents did not.
doi:10.1371/journal.pone.0089482.t003

Kulkarni 2010India

323

–

–

78

–

167

552

110

145

346

283

–

183

ALL

–

–

–

Wang 2011 China

AML

–

–

–

–

Gupta 2009 El Salvador

–

–

ALL

Retinoblastoma

Carlos 2002 Mexico

Brazil

Non-Hodgkin
Lymphoma

Pedrosa 2007Brazil

Viana 1998

Hodgkin
Lymphoma

Dinand 2007 India

China

ALL

Mostert 2010 Indonesia

–

High risk ALL

–

–

–

–

–

–

N

Standard risk ALL 260

Malignancy

Bonilla 2010 El Salvador

Country

Table 3. Eligible studies examining the impact of socioeconomic status upon outcome in children with cancer in low- and middle-income countries.
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Figure 2. Associations between socioeconomic measures and event-free and overall survival in low- and middle-income countries.
A. Measures of material possession, family composition, insurance status, immigrant status, and health care accessibility. B. Measures of education
and occupation. C. Measures of income. Positive = lower socioeconomic status associated with inferior outcome; Negative = lower socioeconomic
status associated with superior outcome. Magnitudes of association are not plotted. Statistically significance is denoted in red. Data points with a
number above represent multiple socioeconomic variables.
doi:10.1371/journal.pone.0089482.g002

the relationship is causal and that no significant bias or confounding exists. Attributable risks were also calculated for recently
discovered biologic prognosticators as comparators. These prognosticators were chosen by the authors based on their prominence
in either clinical practice (e.g. minimally residual disease) or
laboratory research (e.g. CRLF2 expression).

graph in which sample size was represented on the x-axis. Positive
associations (defined as higher SES associated with better outcome) were placed to the right of the y-axis while negative
associations (defined as higher SES associated with worse outcome)
were placed to the left, regardless of statistical significance or
magnitude. Points more distal from the y-axis therefore do not
represent greater degrees of association. When the SES measure
was categorical (e.g. income quintiles), the direction of the
association was determined by comparing outcomes between the
highest and lowest SES categories. For each study, associations for
only the highest aggregation of cancers were presented. Statistically significant associations were displayed in red and nonsignificant associations in black.
For studies describing the effect of dichotomous measures of
income or insurance upon EFS, OS or DFS in acute lymphoblastic
leukemia (ALL) or Hodgkin lymphoma (HL), the proportion of
adverse outcomes attributable to low SES (attributable risk) was
calculated by the following formula (pe = proportion of the
population exposed to the adverse prognosticator; RR = ratio of
the cumulative incidence of adverse outcome in the two groups):
[20] pe ðRR{1Þ=½pe ðRR{1Þz1 ALL and HL were chosen as
they account for a significant percentage of incident cases of
childhood cancer. The concept of attributable risk assumes that
PLOS ONE | www.plosone.org

Ethics Statement
Institutional review board approval was not required as only
group-level, and not individual-level data were obtained from
already published studies.

Results
Figure 1 illustrates the flow of study identification and selection.
A total of 7,737 abstracts were identified by the search strategy;
527 articles in ten languages were retrieved for full evaluation. Of
these, 36 met eligibility criteria. The kappa statistic of agreement
between the two reviewers was 0.82 (95% confidence interval (CI)
0.72–0.91). Characteristics of the included studies, including
indicators of study quality, are shown in Table 2. Though most
studies were of acceptable quality, only half accounted for
potential confounders.
5
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Greece

Spain

England, Wales

Greece

Moschovi 2007

Perez-Martinez 2007d

Tseng 2006

Charalampopolou 2004

England

Birch 2008b,c

USA

Hsieh 2009

USA

UK

Crouch 2009c

Kent 2009

Australia

Youlden 2011

Ireland

Walsh 2011b

–

–

Norway

Syse 2012

Italy

England, Scotland,
Wales

Lightfoot 2012

–

England

Hann 1981

Rondelli 2011

OS

–

–

OS

5 year OS

5 year OS

OS

5 year OS

OS

OS

5 year OS

5 year OS

5 year OS

OS

OS

5 year EFS

–

EFS

USA, Canada

Bhatia 2002

EFS

USA

Outcome
Measure

Metzger 2008

Country

ALL

Malignant CNS

All cancers

MB

All Cancers

Leukemias

NB

All cancers

Cancers

All Cancers

ALL

–

Cancers

ALL

ALL

–

ALL

Hodgkin lymphoma

Malignancy

293

3169

90+

50

31722

4158

1777

654

6289

1440

3522

–

6280

1559

209

–

1596

327

N

–

Carstairs
index NS

–

–

Affluent 71% to
deprived 70%;
trend p = 0.001

–

–

.

–

–

–

–

–

Census-based
deprivation
index NS

–

–

–

Maternal
education NS

–

–

Maternal education NS

–

–

–

–

–

–

–
–

–
.

HR 2.85; Other vs.
married

–

Immigrant status NS

Place of residence NS

–

HR 1.56; Any
insurance vs.
none/unknown

5-year OS Urban
county 63% OS vs.
rural county 55%; p = 0.04

–

HR 1.55; Remote
vs. Major city

–

HR 1.70; Immigrant
vs. non-immigrant

Number of children NS

Marital status NS

OR 1.2; #High
school vs. $College

Household
income NS

Affluent 70% OS to
deprived 64%;
trend p,0.5

Disadvantage
index NS

SAHRU
deprivation
index
NS

–

–

–

–

–

–

–

Other SES Measures

–

–

HR 1.29;
Deprived vs.
affluent

Paternal occupation
NS

Maternal education
NS

Paternal education
NS

–

Education Measuresa

Paternal occupation
NS

–

–

–

–

Annual household
income NS

–

HR 1.9; High
poverty county
vs. low
–

Income Measures

Ecologic Measures

Table 4. Eligible studies examining the impact of socioeconomic status upon outcome in children with cancer in high-income countries.

Socioeconomic Status and Childhood Cancer

February 2014 | Volume 9 | Issue 2 | e89482

PLOS ONE | www.plosone.org

7

–

–

–

–

USA

Netherlands

Coebergh 1996

Szklo 1978

England, Wales

Schillinger 1999

Australia

UK

McKinney 1999e

McWhirter 1983

–

–

–

–

–

–

–

–

–

–

–

–

–

–

Greece

–

–

Petridou 1994

–

–

USA

England, Wales

Coleman 1999

Hord 1996

–

Country

–

Table 4. Cont.

2 year OS

5 year OS

–

–

OS

5 year OS

–

–

5 year OS

5 year OS

OS

–

–

–

–

–

–

–

5 year OS

–

Outcome
Measure

ALL

ALL

–

–

Leukemias

ALL

AML

High-risk ALL

Standard-risk ALL

ALL

All Cancers

GCT

STS

ES

OST

Wilms

CNS

NHL

Hodgkin lymphoma

–

Malignancy

55

70

–

–

120

178

67

141

367

5566

1979

121

319

97

117

257

1050

273

189

–

N

–
–

High rental
value 51% OS
vs. low rental
value 28%; p,0.005

–

–

.

–

–

–

–

–

High social class 59%
OS vs. low 27%
–

Ability to choose doctor NS

Maternity hospital type NS

HR 0.29; Private car vs. none

OR 0.61; Total insurance coverage
vs. at least partially uncovered

–

–

–

–

–

–

–

–

–

–

–

–

–

HR 0.63;
Per child

Other SES Measures

Maternal
education NS

Paternal
education NS

Paternal
occupation NS

–

Parental
education NS

Parental
education NS

Parental
education NS

–

–
–

–

–

–

–

–

–

–

–

–

–

Education Measuresa

–

–

–

–

–

–

–

–

–

–

Income Measures

–

–

–

–

–

–

–

–

Carstairs
index NS

Carstairs
index NS

Carstairs
index NS

Carstairs
index NS

Carstairs
index NS

Carstairs
index NS

Carstairs
index NS

Carstairs
index NS

Carstairs
index NS

Carstairs
index NS

–

Ecologic Measures

Socioeconomic Status and Childhood Cancer
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–

USA

–

Walters 1972f

PLOS ONE | www.plosone.org

ALL – acute lymphoblastic leukemia; AML – acute myeloid leukemia; CNS – central nervous system tumors; EFS – event free survival; ES – Ewing sarcoma; GCT – germ cell tumors; HR – hazard ratio; LR – log rank; MB –
medulloblastoma; N – number; NB – neuroblastoma; NHL – non-Hodgkin lymphoma; OR – odds ratio; OS – overall survival; OST – osteosarcoma; RR – relative risk; SES – socioeconomic status; STS – soft tissue sarcoma; UK – United
Kingdom; USA – United States of America.
Bolded variables indicate statistically significant associations. Magnitudes of non-significant associations and confidence intervals of significant associations can be found in Table S2, along with definitions of each variable.
a
Education measures also include occupation-based measures.
b
Individual malignancies within the overall category showed no significant association between SES and outcome.
c
Adolescent and young adult population.
d
Immigrant patients from one center were compared to a historical control.
e
Within the overall malignancy category, leukemias did show a significant association between lower SES and inferior outcome.
f
No statistical analysis was presented, though the authors state that survival was ‘‘directly related to SES’’.
doi:10.1371/journal.pone.0089482.t004

–
16.2 months lowest SES
vs. 24.3 months
highest
Median
duration

ALL

334

–

–

–
–
AML (Age 10–19)

102

Community
poverty level NS

–

–
–
USA

Median
duration

AML (Age 0–9)

84

Community
poverty level NS

–

Other SES Measures

Byrne 2011

Table 4. Cont.

Country

Outcome
Measure

Malignancy

N

Ecologic Measures

Income Measures

Education Measuresa

Socioeconomic Status and Childhood Cancer

Low- and Middle-income Country Studies
The results of the ten eligible LMIC studies are shown in
Table 3, with full details available in Table S1. Of the ten, seven
found at least one measure of low SES to be significantly associated with inferior outcome.[21–27] The remaining three found
no significant association.[28–30] When restricted to studies examining the primary outcomes of EFS, OS or DFS, 6/7 (85.8%)
studies showed at least one statistically significant association
where lower SES was associated with worse survival.
Figure 2 illustrates each association between a socioeconomic
variable and outcome plotted by study sample size, restricted to
LMIC studies examining EFS, OS or DFS. One Brazilian study of
non-Hodgkin lymphoma provided log rank p values of without
information on the directions of association; none of these were
statistically significant. [30] Regardless of the SES measure chosen,
lower SES was always associated with inferior EFS/OS/DFS, with
the majority of associations statistically significant. There were no
studies that showed that lower SES was associated with better
survival irrespective of statistical significance.

High-income Country Studies
The results of the 26 eligible studies conducted in HIC are
shown in Table 4, all of which used EFS or OS as their outcome.
Full details are available in Table S2. Individual-level and ecologic
measures of SES were used by 13 (50.0%) and 10 (38.5%) studies
respectively; three studies (11.5%) used both. Of the 26, 14
(53.8%) showed at least one measure of low SES to be significantly
associated with inferior outcome.[10,31–43].
Figure 3 illustrates each HIC association plotted by the study
sample size. Of the 21 measures of association between ecologic
SES variables and outcome, 15 (71.4%) showed lower SES to be
associated with worse survival, five of which were statistically
significant. The remaining six (28.6%) showed that lower SES was
associated with superior outcome, none of which were statistically
significant.
Of the 15 measures of association between individual parental
education and outcome, ten (66.7%) showed that lower parental
education was associated with worse survival, three of which were
statistically significant. None of the five (38.5%) associations in
which higher parental education was associated with worse
survival were statistically significant.
Two studies examined the impact of family income. In one
study, there was no association between annual income categorized above and below $30,000 and EFS (HR = 1.0). [44] The
second study found that lower income was associated with worse
OS though the association was not statistically significant. [42].
Of the 14 associations between the remaining individual-level
SES variables and outcome, 12 (85.7%) showed that worse SES
was associated with inferior outcome, seven of which were
statistically significant. Two (14.3%) studies showed that better
SES was associated with worse outcome. One of these two was
statistically significant; among children with ALL in Greece, a
higher number of siblings was associated with a lower risk of death
(HR 0.63 per child; 95% CI 0.40–0.99). [10].
Figure S1 illustrates all associations between SES measures
(individual or ecologic) and outcome from the subset of HIC
studies conducted in the United States. Of eleven associations,
eight (72.7%) showed that lower SES was associated with worse
outcome; two were statistically significant. There were three
associations in which better SES was associated with worse
survival; none were statistically significant.
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Figure 3. Associations between socioeconomic measures and event-free and overall survival in high-income countries. A. Ecologic
measures B. Measures of material possession, family composition, insurance status, immigrant status, and health care accessibility. C. Measures of
education and occupation. D. Measures of income. Positive = lower socioeconomic status associated with inferior outcome; Negative = lower
socioeconomic status associated with superior outcome. Magnitudes of association are not plotted. Statistically significance is denoted in red. Data
points with a number above represent multiple socioeconomic variables. 3* indicates 2 non-significant associations and one significant association.
doi:10.1371/journal.pone.0089482.g003

Based on this framework, our finding that all measures of low
SES in LMIC were associated with inferior outcome implies that
in these settings, many mechanisms link SES and outcome.
Interventions targeting a particular mechanism in LMIC are
therefore likely to decrease but not erase socioeconomic gradients
in outcome. For example, while the provision of free treatment,
accommodation and transport to families in El Salvador resulted
in a decrease in abandonment rates to 13%, socioeconomic
variables remained the strongest predictors of abandonment. [46]
Multi-faceted interventions are thus required in order to
completely eliminate the negative influence of poor SES in LMIC.
Turning to studies conducted in HIC, income-based measures
of SES were not significantly associated with outcome, though
were infrequently investigated. By contrast, measures encompassing paternal education, material possession, and insurance status
were often statistically associated with inferior outcome. This
contrast to the LMIC findings has several potential explanations.
First, a negative influence of low SES in HIC may be present but
weaker than in LMIC, such that HIC studies were more likely to
be underpowered. As the majority of non-significant associations
were in the direction of low SES being associated with inferior
outcome, this hypothesis is plausible.
Alternatively, only some of the pathways illustrated in Figure 4
may be relevant in HIC. Interestingly, both American studies
examining the effect of insurance coverage found the lack of full
coverage to be significantly associated with inferior survival. [34,47]
In HIC, measures of access to health care may therefore be more

Attributable Risk
Table 5 shows the proportion of adverse outcomes attributable
to low socioeconomic measures of income or insurance as calculated from LMIC and HIC studies. Based on the selected studies,
and assuming both causality and the absence of significant bias or
confounding, eliminating the adverse effect of low socioeconomic
status would result in a theoretical 22.9% to 74.8% reduction in
adverse outcome among LMIC children. Among HIC children,
0.0% to 31.9% of adverse outcomes could be avoided.

Discussion
In this systematic review, we found that among children with
cancer in LMIC, measures of low SES were uniformly associated
with inferior outcome. The majority of these associations were statistically significant. The results in HIC were less uniform although
the majority of associations (including all but one of the statistically
significant associations) also linked lower SES and worse outcome.
We chose to include multiple measures of SES in this systematic
review, as SES indicators measure ‘‘different, often related aspects
of socioeconomic stratification and may be more or less relevant to
different health outcomes.’’ [45] This issue may be particularly
pronounced in pediatric oncology, where mechanisms linking SES
and outcome are likely complex and inter-related, as illustrated in
Figure 4. These mechanisms have been suggested by previous
authors as outlined in the figure legend, but are often theoretical
with little empiric basis.
PLOS ONE | www.plosone.org
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Table 5. Proportion of adverse outcomes (attributable risk) due to poor socioeconomic prognosticators in studies of the effect of
dichotomous measures of income and insurance in acute lymphoblastic leukemia and Hodgkin lymphoma, as well as of selected
biologic prognosticators by way of comparison.

Malignancy Country

Category Adverse Prognosticator

pe

RR AR

Dinand 2007

HL

India

LMIC

Low SES, based on aggregate score including income

0.67 5.4 74.8%

Mostert 2010

ALL

Brazil

LMIC

Monthly per capita income ,0.4 6minimum wage

0.25 1.2 22.9%

Viana 1998

ALL

Indonesia

LMIC

2nd/3rd class ward, based on income

0.76 2.6 55.0%

Tang 2008

ALL

China

LMIC

Rural residence/no insurance

0.74 1.8 37.1%

Bhatia 2002

ALL

USA, Canada

HIC

Annual household income ,$30,000

0.56 1.0 0.0%

Hord 1996

ALL

USA

HIC

At least partially uncovered by insurance

0.29 1.6 15.7%

Lightfoot 2012

ALL

England, Scotland, Wales

HIC

Deprived area, based in part on income

0.39 1.3 10.2%

Metzger 2008

HL

USA

HIC

County with high % children in poverty

0.52 1.9 31.9%

Borowitz 2008

SR-ALL

Multiple

HIC

MRD.0.01%

0.14 7.2 45.6%

Borowitz 2008

HR-ALL

Multiple

HIC

MRD.0.01%

0.30 3.2 39.4%

Loken 2012

AML

Multiple

HIC

Residual disease by flow cytometry

0.22 2.17 20.5%

Chen 2012

ALL

Multiple

HIC

High CRLF2 expression

0.18 1.86 13.1%

ALL – acute lymphoblastic leukemia; AML – acute myeloid leukemia; AR – attributable risk; HIC – high-income country; HL – Hodgkin lymphoma; LMIC – low- to middleincome country; MRD – minimal residual disease; pe – proportion of population exposed to the adverse prognosticator; RR – risk ratio; SES – socioeconomic status.
doi:10.1371/journal.pone.0089482.t005

allowing for the role of biologic confounders to be minimized. Our
main limitation was the inability to compare magnitudes of
associations across studies. Even when multiple studies used both
the same outcome (e.g. EFS) and exposure (e.g. income), different
units of analysis were used (richest income quintile vs. poorest
income quintile, per $100 monthly income). In previous work we
showed the effect of monthly income upon EFS in children with
ALL in El Salvador was HR = 0.81 per $100. [28] Comparing the
richest quartile to the poorest in the identical population would
have resulted in a HR of 0.45. Thus meaningful comparisons can
only be made when the analysis unit is identical. This also
rendered the use of Forest plots inappropriate. Our figures instead
were restricted to illustrating effect direction and significance. In
the future, individual-level meta-analyses may be useful in this
regard as long as the non-categorized covariate (e.g. monthly
income) was collected. Secondly, it is possible that publication bias
is present, particularly in studies of LMIC. Finally, the incidence of
ALL has itself been linked to high SES in some studies. [51] For
this to explain the findings of our systematic review, the biologic
driver behind this association would have to be specific to a lowrisk form of ALL across multiple populations. While we cannot
rule this possibility out, this would not explain the association
between SES and outcome seen in other cancers.
In conclusion, low SES is uniformly associated with poorer
outcomes among LMIC children with cancer, and widespread
among HIC children. Future studies should identify specific
mechanisms underlying these gradients, as well as evaluate
interventions aimed at improving the outcome of children with
cancer with socioeconomic risk factors.

relevant than, for example, measures of income. It is also likely that
the impact of different aspects of SES will vary between settings and
malignancies. For example, different measures of SES are likely to
be relevant in countries with universal access to health care than in
those without. Compliance will have a greater potential effect upon
outcome in malignancies for which outpatient oral chemotherapy
plays a major role than those involving mainly inpatient therapy.

Implications for Future Studies
Future studies must move beyond choosing socioeconomic
variables and outcomes based simply on what data are easily
available to the investigators. Instead, authors should posit specific
mechanisms and potential confounders in advance, identify
measures of SES and outcomes consistent with the hypothesis,
and only then examine for significant associations. For example,
Bhatia et?al. measured rates of compliance to oral chemotherapy
among American children with ALL. Low rates of compliance were
linked to single mother households and associated with higher rates
of relapse. [48] Demonstrating the role of a particular pathway
thus not only leads to a deeper understanding of the impact of
SES, but also to plausible interventions mediating the pathway.
While such studies are likely to be complex, their impact may be
significant. We have shown that improving the outcome of
children of low SES to that of their high SES brethren would result
in the elimination of up to 74.8% of adverse outcomes in LMIC
and up to 31.9% of adverse outcomes in HIC. By way of
comparison, minimal residual disease accounts for a theoretical
39.4% of relapse in high-risk ALL, while the novel feature of high
CRLF2 expression accounts for 13.1% of relapse among all
children with ALL. [49,50] Consequently, debate on how low SES
can be targeted is warranted, both in LMIC and HIC. Targeted
interventions could encompass more frequent follow-up, intensive
compliance monitoring, or other stratagems.

Supporting Information
Figure S1 Associations between socioeconomic measures and event-free and overall survival in studies
conducted in the United States. Positive = lower socioeconomic status associated with inferior outcome; Negative = lower
socioeconomic status associated with superior outcome. Magnitudes of association are not plotted. Thus points distal from the y-

Strengths and Limitations
This study represents the first comprehensive assessment of the
effect of SES on children with cancer. Other strengths include the
lack of language-based restrictions and the exclusion of ethnicity,
PLOS ONE | www.plosone.org
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Figure 4. Mechanisms linking socioeconomic status domains to both general and childhood cancer specific health outcomes.
Domains and general mechanisms are adapted from the work of Galobardes et?al., Braveman et?al., Krieger et?al. and Marmot. Several childhood
specific mechanisms are suggested by Bhatia et?al., Gage, Viana et?al. and Gupta et?al. These mechanisms are often theoretical with little empiric
basis.
doi:10.1371/journal.pone.0089482.g004

axis may represent stronger, weaker or equivalent associations
than proximal points.
(DOCX)

OST – osteosarcoma; RR – relative risk; SES – socioeconomic
status; STS – soft tissue sarcoma; UK – United Kingdom; USA –
United States of America. Bolded variables indicate statistically
significant associations. aIndividual malignancies within the overall
category showed no significant association between SES and outcome. bAdolescent and young adult population. cWithin the overall
malignancy category, leukemias did show a significant association
between lower SES and inferior outcome. dImmigrant patients from
one center were compared to a historical control. eNo statistical
analysis was presented, though the authors state that survival was
‘‘directly related to SES’’. fHR is per level of occupation.
(DOCX)

Eligible studies examining the impact of
socioeconomic status upon outcome in children with
cancer in low- and middle-income countries. ALL – acute
lymphoblastic leukemia; AML – acute myeloid leukemia; DFS –
disease free survival; EFS – event free survival; HR – hazard ratio;
N – number; OS – overall survival; SES – socioeconomic status;
TRM – treatment related mortality. Bolded variables indicate
statistically significant associations. aThe marginalization index
used by Carlos et?al. is an ecologic measure of SES; all other
variables in the table are measures of individual-level SES.
(DOCX)
Table S1

Text S1 Study Protocol.

(DOCX)

Eligible studies examining the impact of
socioeconomic status upon outcome in children with
cancer in high-income countries. ALL – acute lymphoblastic
leukemia; AML – acute myeloid leukemia; CNS – central nervous
system tumors; EFS – event free survival; ES – Ewing sarcoma;
GCT – germ cell tumors; HR – hazard ratio; MB –
medulloblastoma; N – number; NB – neuroblastoma; NHL –
non-Hodgkin lymphoma; OR – odds ratio; OS – overall survival;

Table S2
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